NZ Skin Cancer Research Review Issue 19
In this issue:
– Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma
– Incidence, mortality and survival of MCC
– Nivolumab-tacrolimusprednisone ± ipilimumab for kidney transplant recipients with cutaneous cancers
– Topical treatment of cutaneous SCC in situ
– Predicting survival in patients with stage II melanoma
– Full-body skin examination in cutaneous malignancy screening
– Dose escalation of personalised peptide-based neoantigen vaccine for metastatic melanoma
– Association between dermatology follow-up and melanoma survival
– Extended-dosing cemiplimab in advanced cutaneous SCC
– SLNB unreliable for predicting melanoma mortality regardless of age
Expert contributor
Dr Junie Wong
Dr. Junie Wong is a Consultant Dermatologist and Mohs Micrographic Surgeon. She graduated from the University of Edinburgh Medical School and completed her postgraduate dermatology training in Liverpool, UK, before moving to New Zealand. She is a Fellow of the American College of Mohs Surgery, the Royal College of Physicians of Edinburgh, the Royal Australasian […]
Expert contributor
Dr Annie Wong
Dr Annie Wong is a NZ-trained medical oncologist currently based at Peter MacCallum Cancer Centre, Melbourne. Her oncological specialities include melanoma, lung cancer, and head and neck cancer. Her research interests include the management of melanoma brain metastases, mucosal melanoma and immunotherapy-related toxicities.
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.
